Beyond ROS: Decoding Mitochondrial Signaling [Jul. 15, 2026]

Previous Science Note  

Recent studies suggest that understanding mitochondrial ROS signaling requires evaluating not only ROS levels, but also the site and mechanism of ROS production, mitochondrial membrane potential, glycolytic and oxidative metabolism, and downstream cellular responses. In macrophages exposed to a bacterial component, elevated membrane potential and succinate oxidation supported reverse electron transport at Complex I, defining the metabolic conditions that generate superoxide capable of regulating inflammatory cytokine release. In lipid-loaded macrophages, mitochondrial superoxide activated a gene regulatory pathway that contributed to impaired respiration and reinforced further ROS production and lipid accumulation.

Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1β release during NLRP3 inflammasome activation
(Casey et al., Nature Metabolism, 2025)

Summary
In this study, the authors show how inflammatory macrophages generate signaling superoxide after exposure to a bacterial component. Reduced ATP synthase dependence elevated mitochondrial membrane potential, while succinate oxidation maintained reduced CoQ, enabling reverse electron transport at Complex I. The resulting superoxide regulated release of an inflammatory cytokine, linking a defined respiratory mechanism of ROS production to control of the macrophage inflammatory response.

Highlighted technique
To identify the metabolic conditions supporting mitochondrial superoxide production, the study combined confocal imaging of superoxide and membrane potential with Seahorse measurements of OCR and ECAR and quantification of ATP to ADP ratios, lactate, succinate, and CoQ redox state.

As a complementary approach, intact mitochondria isolated from tissues can be analyzed for OCR and Complex I activity to assess the electron transport chain conditions underlying mitochondrial ROS generation.


Mitochondrial ROS drive foam cell formation via STAT5 signaling in atherosclerosis
(Boccuni et al., Science Advances, 2025)

Summary
In this study, the authors show that uptake of oxidatively modified LDL, a lipid particle that accumulates in atherosclerosis, does more than increase mitochondrial oxidative stress. In human and mouse macrophages, mitochondrial superoxide activates STAT5, a signaling protein that regulates gene expression and metabolism. STAT5 increased CD36 expression and contributed to impaired pyruvate dehydrogenase activity and respiration, creating a self reinforcing loop that promoted lipid uptake and foam cell formation.

Highlighted technique
To examine how mitochondrial ROS promotes lipid accumulation and associated metabolic remodeling, the study measured mitochondrial superoxide, membrane potential, and neutral lipids during ROS scavenging and inhibition of STAT5, a regulator of gene expression and metabolism, and quantified OCR and ECAR to assess changes in glycolysis and OXPHOS.

Evaluating mitochondrial ROS and membrane potential together with OCR, glycolysis/OXPHOS balance, and lipid droplet accumulation may help capture how metabolic changes develop into a lipid accumulating cellular state.


 


Mitochondrial Related Activity Indicators (click to open/close)
Target Kit & Probes
Mitochondrial superoxide detection MitoBright ROS Deep Red - Mitochondrial Superoxide Detection
Intracellular ATP mesurement ATP Assay Kit-Luminescence
ATP/ ADP ratio mesurement ADP/ATP Ratio Assay
Oxygen consumption rate assay Extracellular OCR Plate Assay Kit
Glycolysis/Oxidative phosphorylation Assay Glycolysis/OXPHOS Assay Kit
Mitochondrial Staining MitoBright LT Green / Red / Deep Red
Intact Mitochondria Fractionation IntactMito Fractionation Kit for Tissue
MitoComplex-I Activity Assay MitoComplex-I Activity Assay Kit
Glycolysis/Oxidative phosphorylation Assay Glycolysis/OXPHOS Assay Kit
Mitochondrial membrane potential detection JC-1 MitoMP Detection Kit, MT-1 MitoMP Detection Kit
Application Note I (click to open/close)
> Inhibition of Mitochondrial Electron Transport Chain

Antimycin stimulation of Jurkat cells was used to evaluate the changes in cellular state upon inhibition of the mitochondrial electron transport chain using a variety of indicators.

The results showed that inhibition of the electron transport chain resulted in (1) a decrease in mitochondrial membrane potential and (2) a decrease in OCR. In addition, (3) the NAD+/NADH ratio of the entire glycolytic pathway decreased due to increased metabolism of pyruvate to lactate to maintain the glycolytic pathway, (4) GSH depletion due to increased reactive oxygen species (ROS), and (6) increase in the NADP+/NADPH ratio due to decreased NADH required for glutathione biosynthesis were observed.

 

   

  

Application Note II (click to open/close)
> Activity Evaluation of Mitochondria Fractionated from Mouse Brain

 

Mitochondria were isolated from mouse brain tissue, and oxygen consumption rate (OCR), mitochondrial membrane potential (MMP), and Complex I activity were measured.

The results showed that the addition of succinate, a substrate that activates Complex II of the electron transport chain, increased both OCR and MMP. In contrast, FCCP treatment reduced MMP, indicating that intact mitochondria were successfully fractionated.
Furthermore, in the Complex I activity assay, a decrease in activity was observed following treatment with rotenone, a Complex I inhibitor.

<Product used>
    Mitochondrial Fractionation: 
 IntactMito Fractionation Kit for Tissue (Code: MT17)
 OCR measurement: 
 Extracellular OCR Plate Assay Kit (Code: E297)
 MMP detection: 
 JC-1 MitoMP Detection Kit (Code: MT09)
 Complex I activity assay:  
 MitoComplex- I Activity Assay Kit (Code: MT18)

<Experimental Conditions>
OCR Measurement   
    Amount of mitochondria: 50 μg/well (as protein levels)
    Succinate: 10 mmol/l
MMP Detection  
    Amount of mitochondria: 50 μg/well (as protein levels)
    Succinate: 10 mmol/l,   FCCP: 4 μmol/l
Complex I Activity Assay  
    Amount of mitochondria: 20 μg/well (as protein levels)
       Rotenone: 10 μmol/l

 
 
 
 

Product Classification

Product Classification